[go: up one dir, main page]

DK359387D0 - Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling - Google Patents

Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling

Info

Publication number
DK359387D0
DK359387D0 DK359387A DK359387A DK359387D0 DK 359387 D0 DK359387 D0 DK 359387D0 DK 359387 A DK359387 A DK 359387A DK 359387 A DK359387 A DK 359387A DK 359387 D0 DK359387 D0 DK 359387D0
Authority
DK
Denmark
Prior art keywords
solutions
preparation
oxazaphosphorines
procedure
improved stability
Prior art date
Application number
DK359387A
Other languages
English (en)
Other versions
DK168322B1 (da
DK359387A (da
Inventor
Dieter Sauerbier
Klaus Molge
Werner Weigert
Otto Isaac
Original Assignee
Asta Werke Ag Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Werke Ag Chem Fab filed Critical Asta Werke Ag Chem Fab
Publication of DK359387D0 publication Critical patent/DK359387D0/da
Publication of DK359387A publication Critical patent/DK359387A/da
Application granted granted Critical
Publication of DK168322B1 publication Critical patent/DK168322B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Paper (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
DK359387A 1986-07-11 1987-07-10 Ethanoliske opløsninger af oxazaphosphoriner med forbedret stabilitet DK168322B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3623369 1986-07-11
DE3623369 1986-07-11

Publications (3)

Publication Number Publication Date
DK359387D0 true DK359387D0 (da) 1987-07-10
DK359387A DK359387A (da) 1988-01-12
DK168322B1 DK168322B1 (da) 1994-03-14

Family

ID=6304930

Family Applications (1)

Application Number Title Priority Date Filing Date
DK359387A DK168322B1 (da) 1986-07-11 1987-07-10 Ethanoliske opløsninger af oxazaphosphoriner med forbedret stabilitet

Country Status (16)

Country Link
US (1) US4952575A (da)
EP (1) EP0254902B1 (da)
JP (1) JPS6323888A (da)
KR (1) KR880001282A (da)
AT (1) ATE66609T1 (da)
AU (1) AU598282B2 (da)
CA (1) CA1289886C (da)
DE (2) DE3772482D1 (da)
DK (1) DK168322B1 (da)
ES (1) ES2038623T3 (da)
FI (1) FI86690C (da)
GR (1) GR3002618T3 (da)
IE (1) IE59897B1 (da)
IL (1) IL83141A (da)
PT (1) PT85293B (da)
ZA (1) ZA875059B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051257A (en) * 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
DE59813853D1 (de) * 1997-10-13 2007-02-01 Stada Arzneimittel Ag Flüssige darreichungsformen oxazaphosphorinhaltiger pharmazeutischer produkte
US7205404B1 (en) 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
AUPQ849900A0 (en) * 2000-06-30 2000-07-27 Dbl Australia Pty Ltd. Injectable composition
US6613927B1 (en) 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods
BR0314068A (pt) * 2002-09-05 2005-07-05 Bharat Serums & Vaccines Ltd Processo para a preparação de uma composição estável com baixo nìvel de toxicidade; composição estável que contém oxazafosforina; uso de uma composição estável que contém oxazafosforina; e método de tratamento de uma doença maligna
US7199111B2 (en) * 2002-12-02 2007-04-03 Bharat Serums & Vaccines Ltd. Aqueous ifosfamide compositions for parenteral administration and a process for their preparations
MX2007002941A (es) * 2004-09-13 2007-05-24 Bharat Serums & Vaccines Ltd Composiciones de emulsion estables para administracion intravenosa que tienen eficacia libre de conservadores.
WO2015123352A1 (en) 2014-02-13 2015-08-20 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
BR112016026140A2 (pt) * 2014-05-09 2018-08-07 AuroMedics Pharma LLC formulações de concentrado líquido de ciclofosfamida.
CN106687118A (zh) 2014-07-02 2017-05-17 配体药物公司 前药化合物及其用途
US10849916B2 (en) 2014-07-11 2020-12-01 Dr. Reddys Laboratories Limited Stable liquid formulations of cyclophosphamide and its impurities
WO2016005962A2 (en) 2014-07-11 2016-01-14 Dr. Reddy’S Laboratories Limited Stable liquid formulations of cyclophosphamide and processes
WO2016132270A1 (en) 2015-02-16 2016-08-25 Leiutis Pharmaceuticals Pvt Ltd Stable ready to use cyclophosphamide liquid formulations
CN111788196A (zh) 2018-01-09 2020-10-16 配体药物公司 缩醛化合物及其治疗用途
WO2022038072A1 (en) * 2020-08-17 2022-02-24 Sandoz Ag Parenteral pharmaceutical composition comprising cyclophosphamide and a mixture of liquids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3530147A1 (de) * 1985-08-23 1987-02-26 Bayer Ag Verwendung von diazaphosphorinen zur bekaempfung von endoparasiten

Also Published As

Publication number Publication date
AU7554987A (en) 1988-01-14
IL83141A (en) 1992-11-15
IE871867L (en) 1988-01-11
DE3722043A1 (de) 1988-01-14
DK168322B1 (da) 1994-03-14
GR3002618T3 (en) 1993-01-25
ZA875059B (en) 1988-02-24
EP0254902B1 (de) 1991-08-28
DE3772482D1 (de) 1991-10-02
FI873064A0 (fi) 1987-07-10
JPH0543711B2 (da) 1993-07-02
FI873064L (fi) 1988-01-12
FI86690B (fi) 1992-06-30
PT85293A (de) 1987-08-01
DK359387A (da) 1988-01-12
FI86690C (fi) 1992-10-12
PT85293B (pt) 1990-03-30
EP0254902A3 (en) 1988-08-03
US4952575A (en) 1990-08-28
IE59897B1 (en) 1994-04-20
KR880001282A (ko) 1988-04-22
ES2038623T3 (es) 1993-08-01
IL83141A0 (en) 1987-12-31
JPS6323888A (ja) 1988-02-01
EP0254902A2 (de) 1988-02-03
ATE66609T1 (de) 1991-09-15
CA1289886C (en) 1991-10-01
AU598282B2 (en) 1990-06-21

Similar Documents

Publication Publication Date Title
DK359387A (da) Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling
DK499088D0 (da) 1-oe(2-pyrimidinyl)-aminoalkylaapiperidinderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne derivater
NO172437C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidindionforbindelser
DK283487D0 (da) Thiazolyl-2-yl-imidazo(1,2-a)pyrimidiner, deres fremstilling og brug
NO895002L (no) Enzymhemmende aminosyrederivater.
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
DK640687A (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
DK440987A (da) Thyroninderivater, deres fremstilling og anvendelse
ATE139441T1 (de) Verwendung von 2-iminothiazolidin-4-onderivaten als neuartige arzneimittelwirkstoffe
NO164352C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive, antivirale, substituerte isoksazolderivater.
ATE70838T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE22284T1 (de) 2-aminomethyl-6-sulfamoylphenolderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
ATE61341T1 (de) N-substituierte, estergruppen enthaltende acrylamide.
SE8302452D0 (sv) Method for treatment of senile dementia
ES2058542T3 (es) Imidas biciclicas puenteadas de 4-(4-(3-benzoisotiazolil)-1-piperazinil)butilo antipsicoticas.
DK148058C (da) Analogifremgangsmaade til fremstilling af thiazolderivater eller syreadditionssalte deraf
AU573062B2 (en) Dihydrodithiazine derivatives
DK469381A (da) Piperidinderivater og fremgangsmaade til deres fremstilling
EP0200145A3 (en) Process for the preparation of optically active azole derivatives
SE7905862L (sv) Substituerade 4-aryl-2,5-dihydro-furan-2-oner och 4-aryl-1,5-dihydro-2h-pyrrol-2-oner och sett for deras framstellning

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired